Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Bolus vs Infusion for Anesthetic Induction
NCT05423080Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Aug 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam in general anesthesia (2 arms), sponsored by Korea University Guro Hospital. Primary endpoint: Time from initiation of remimazolam to Loss of Consciousness (LOC) assessed by MOAA/SS up to 5 minutes. Started Aug 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05423080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05423080.